Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sindhuvallathy mezhugu is a classical polyherbal formulation from the Siddha system of traditional medicine, used primarily in South India. It is classified as a "mezhugu," which refers to a semi-solid or wax-based internal medicine prepared by grinding or heating herbal and/or mineral ingredients with oily substances. Sindhuvallathy mezhugu has been studied for its efficacy in the management of kidney stones (urolithiasis), where it is administered orally, typically at doses of 100–200 mg with radish juice after food[1][3][4]. The precise mechanism of action is not well characterized in modern pharmacological terms, but Siddha texts attribute its effects to balancing bodily humors and promoting dissolution or expulsion of urinary calculi. The formulation may contain multiple plant-based ingredients; however, specific composition details are not provided in the available sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sindhuvallathy mezhugu.